{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "None", "lead_paragraph": "A Cuban doctor treating Ebola patients in Sierra Leone has tested positive for the disease and was being sent to Geneva for treatment, officials said, the first Cuban known to have contracted the potentially deadly haemorrhagic fever.", "headline": {"main": "Cuban Doctor in Sierra Leone Tests Positive for Ebola", "print_headline": "Cuban Doctor in Sierra Leone Tests Positive for Ebola"}, "abstract": null, "print_page": null, "word_count": "417", "_id": "546c2fc1798810400cefe871", "snippet": "A Cuban doctor treating Ebola patients in Sierra Leone has tested positive for the disease and was being sent to Geneva for treatment, officials said, the first Cuban known to have contracted the potentially deadly haemorrhagic fever.", "source": "Reuters", "slideshow_credits": null, "web_url": "http://www.nytimes.com/reuters/2014/11/19/world/africa/19reuters-health-ebola-cuba.html", "multimedia": [], "subsection_name": "Africa", "keywords": [], "byline": {"person": [], "original": "By REUTERS", "organization": "REUTERS"}, "document_type": "article", "pub_date": "2014-11-19T00:48:16Z", "section_name": "World"}, {"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "Our bodies are home to trillions of viruses, and new research hints that some of them may actually be keeping us healthy.", "headline": {"main": "Viruses as a Cure", "kicker": "Matter", "content_kicker": "Matter"}, "abstract": null, "print_page": null, "word_count": "912", "_id": "546cdbec79881016298c76b8", "snippet": "Our bodies are home to trillions of viruses, and new research hints that some of them may actually be keeping us healthy.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/11/19/science/viruses-as-a-cure.html", "multimedia": [{"subtype": "wide", "url": "images/2014/11/20/science/20zimmer/20zimmer-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/11/20/science/20zimmer/20zimmer-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/11/20/science/20zimmer/20zimmer-articleLarge.jpg", "height": 600, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/11/20/science/20zimmer/20zimmer-articleLarge.jpg", "xlargeheight": "600"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/11/20/science/20zimmer/20zimmer-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/11/20/science/20zimmer/20zimmer-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Viruses", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Digestive Tract", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Research", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Microbiology", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Immune System", "is_major": "N", "rank": "5", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Carl", "lastname": "ZIMMER"}], "original": "By CARL ZIMMER"}, "document_type": "article", "pub_date": "2014-11-19T00:00:00Z", "section_name": "Science"}, {"type_of_material": "Special Report", "blog": [], "news_desk": "Business", "lead_paragraph": "Researchers are optimistic about recent efforts to delay the effects of aging and, perhaps, extend life spans.", "headline": {"main": "Science (and Quacks) vs. the Aging Process ", "print_headline": "Science (and Quacks) vs. the Aging Process", "content_kicker": "Special Section"}, "abstract": "Scientific community is optimistic about efforts to improve longevity, but warns against spending money on products that offer fantastic claims; researchers say, while they are not able to stop or reverse aging, they can slow rate at which people get old and keep people healthier longer.", "print_page": "5", "word_count": "1162", "_id": "546bf5b2798810400cefe7ee", "snippet": "Researchers are optimistic about recent efforts to delay the effects of aging and, perhaps, extend life spans.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/11/19/your-money/science-and-quacks-vs-the-aging-process-.html", "multimedia": [{"width": 190, "url": "images/2014/11/19/your-money/19IMMORTAL1/19IMMORTAL1-thumbWide.jpg", "height": 126, "subtype": "wide", "legacy": {"wide": "images/2014/11/19/your-money/19IMMORTAL1/19IMMORTAL1-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"width": 600, "url": "images/2014/11/19/your-money/19IMMORTAL1/19IMMORTAL1-articleLarge.jpg", "height": 400, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlarge": "images/2014/11/19/your-money/19IMMORTAL1/19IMMORTAL1-articleLarge.jpg", "xlargeheight": "400"}, "type": "image"}, {"width": 75, "url": "images/2014/11/19/your-money/19IMMORTAL1/19IMMORTAL1-thumbStandard.jpg", "height": 75, "subtype": "thumbnail", "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/11/19/your-money/19IMMORTAL1/19IMMORTAL1-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"rank": "1", "is_major": "Y", "value": "Longevity", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Personal Finances", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Research", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Elderly", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "firstname": "Tracey", "rank": 1, "lastname": "SAMUELSON"}], "original": "By TRACEY SAMUELSON"}, "document_type": "article", "pub_date": "2014-11-19T00:00:00Z", "section_name": "Your Money"}, {"type_of_material": "News", "blog": [], "news_desk": "None", "lead_paragraph": "A coalition of companies and aid groups announced plans Tuesday to test experimental drugs and collect blood plasma from Ebola survivors to treat new victims of the disease in West Africa.", "headline": {"main": "Study Will Test Survivors' Blood to Treat Ebola", "print_headline": "Study Will Test Survivors' Blood to Treat Ebola"}, "abstract": null, "print_page": null, "word_count": "759", "_id": "546c0928798810400cefe816", "snippet": "A coalition of companies and aid groups announced plans Tuesday to test experimental drugs and collect blood plasma from Ebola survivors to treat new victims of the disease in West Africa.", "source": "AP", "slideshow_credits": null, "web_url": "http://www.nytimes.com/aponline/2014/11/18/health/ap-us-med-ebola-blood-study.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [], "original": "By THE ASSOCIATED PRESS", "organization": "THE ASSOCIATED PRESS"}, "document_type": "article", "pub_date": "2014-11-18T22:02:46Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "None", "lead_paragraph": "Talent spotters from Novartis AG, charged with bringing new ideas into the organization, are casting their net beyond biotech into the wider pool of wearable, or even edible, technology.", "headline": {"main": "World's Top Drugmaker Novartis Takes Aim at Tech", "print_headline": "World's Top Drugmaker Novartis Takes Aim at Tech"}, "abstract": null, "print_page": null, "word_count": "519", "_id": "546a41757988106d5f6263b9", "snippet": "Talent spotters from Novartis AG, charged with bringing new ideas into the organization, are casting their net beyond biotech into the wider pool of wearable, or even edible, technology.", "source": "Reuters", "slideshow_credits": null, "web_url": "http://www.nytimes.com/reuters/2014/11/17/technology/17reuters-novartis-tech.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [], "original": "By REUTERS", "organization": "REUTERS"}, "document_type": "article", "pub_date": "2014-11-17T13:40:55Z", "section_name": "Technology"}, {"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "The beef industry tries to attract he so-called millennial generation, who are less inclined to eat meat and more likely to encounter advertising on phones and computer screens.", "headline": {"main": "In Texas, Beef Council Hopes to Rope In a Younger Crowd", "print_headline": "Beef Council Hopes to Rope in a Younger Crowd", "content_kicker": "The Texas Tribune"}, "abstract": null, "print_page": "33A", "word_count": "1128", "_id": "5467f42f79881054c64b0720", "snippet": "The beef industry tries to attract he so-called millennial generation, who are less inclined to eat meat and more likely to encounter advertising on phones and computer screens.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/11/16/us/in-texas-beef-council-hopes-to-rope-in-a-younger-crowd.html", "multimedia": [{"width": 190, "url": "images/2014/11/16/us/TTCows/TTCows-thumbWide.jpg", "height": 126, "subtype": "wide", "legacy": {"wide": "images/2014/11/16/us/TTCows/TTCows-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"width": 600, "url": "images/2014/11/16/us/TTCows/TTCows-articleLarge.jpg", "height": 401, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlarge": "images/2014/11/16/us/TTCows/TTCows-articleLarge.jpg", "xlargeheight": "401"}, "type": "image"}, {"width": 75, "url": "images/2014/11/16/us/TTCows/TTCows-thumbStandard.jpg", "height": 75, "subtype": "thumbnail", "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/11/16/us/TTCows/TTCows-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"rank": "1", "is_major": "N", "value": "Beef", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Advertising and Marketing", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Cooking and Cookbooks", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Texas Tribune", "name": "organizations"}, {"rank": "5", "is_major": "N", "value": "Texas", "name": "glocations"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "firstname": "Terri", "rank": 1, "lastname": "LANGFORD"}], "original": "By TERRI LANGFORD"}, "document_type": "article", "pub_date": "2014-11-16T00:00:00Z", "section_name": "U.S."}, {"type_of_material": "Letter", "blog": [], "news_desk": "Letters", "lead_paragraph": "Readers debate whether aid-in-dying rights should be expanded to those who are not terminally ill.", "headline": {"main": "&#8216;Prophylactic&#8217; Suicide", "kicker": "Sunday Dialogue", "print_headline": "\u2018Prophylactic\u2019 Suicide", "content_kicker": "Sunday Dialogue"}, "abstract": null, "print_page": "8", "word_count": "1688", "_id": "5467a9d279881054c64b01c9", "snippet": "Readers debate whether aid-in-dying rights should be expanded to those who are not terminally ill.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/11/16/opinion/sunday/prophylactic-suicide.html", "multimedia": [{"width": 190, "url": "images/2014/11/16/sunday-review/1116LETTERS/1116LETTERS-thumbWide.jpg", "height": 126, "subtype": "wide", "legacy": {"wide": "images/2014/11/16/sunday-review/1116LETTERS/1116LETTERS-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"width": 600, "url": "images/2014/11/16/sunday-review/1116LETTERS/1116LETTERS-articleLarge.jpg", "height": 600, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlarge": "images/2014/11/16/sunday-review/1116LETTERS/1116LETTERS-articleLarge.jpg", "xlargeheight": "600"}, "type": "image"}, {"width": 75, "url": "images/2014/11/16/sunday-review/1116LETTERS/1116LETTERS-thumbStandard.jpg", "height": 75, "subtype": "thumbnail", "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/11/16/sunday-review/1116LETTERS/1116LETTERS-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": "Sunday Review", "keywords": [{"rank": "1", "is_major": "N", "value": "Elderly", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Euthanasia and Assisted Suicide", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Ethics and Official Misconduct", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Dementia", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Living Wills and Health Care Proxies", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Emanuel, Ezekiel J", "name": "persons"}], "byline": [], "document_type": "article", "pub_date": "2014-11-16T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "Magazine", "lead_paragraph": "Our high-tech process of pharmaceutical research is broken \u2014 and the solution might be old-fashioned trial and error.", "headline": {"main": "Why Are So Few Blockbuster Drugs Invented Today?", "print_headline": "Kemia Malekvilibro Chemical Imbalance", "content_kicker": "The Innovations Issue"}, "abstract": "Most drug companies have continued to devote vast majority of their funding to target-based research, informed by genomics, despite fact that more traditional methods of drug discovery like trial-and-error have proved more productive; example of trial-and-error method yielding positive result is research that chemical engineer Todd Zion has done on developing better form of insulin, promise of which has led Merck to acquire Zion's company SmartCells.", "print_page": "61", "word_count": "2742", "_id": "546480e17988104000b1a95f", "snippet": "Our high-tech process of pharmaceutical research is broken \u2014 and the solution might be old-fashioned trial and error.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/11/16/magazine/why-are-there-so-few-new-drugs-invented-today.html", "multimedia": [{"width": 190, "url": "images/2014/11/11/magazine/16insulin1/mag-16insulin-t-thumbWide.jpg", "height": 126, "subtype": "wide", "legacy": {"wide": "images/2014/11/11/magazine/16insulin1/mag-16insulin-t-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"width": 600, "url": "images/2014/11/11/magazine/16insulin1/mag-16insulin-t-articleLarge.jpg", "height": 400, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlarge": "images/2014/11/11/magazine/16insulin1/mag-16insulin-t-articleLarge.jpg", "xlargeheight": "400"}, "type": "image"}, {"width": 75, "url": "images/2014/11/11/magazine/16insulin1/mag-16insulin-t-thumbStandard.jpg", "height": 75, "subtype": "thumbnail", "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/11/11/magazine/16insulin1/mag-16insulin-t-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"rank": "1", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Insulin", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Zion, Todd C", "name": "persons"}, {"rank": "4", "is_major": "Y", "value": "SmartCells", "name": "organizations"}, {"rank": "5", "is_major": "Y", "value": "Merck & Company Inc", "name": "organizations"}, {"rank": "6", "is_major": "N", "value": "Research", "name": "subject"}, {"rank": "7", "is_major": "N", "value": "Genetics and Heredity", "name": "subject"}, {"rank": "8", "is_major": "N", "value": "Science and Technology", "name": "subject"}, {"rank": "9", "is_major": "N", "value": "Massachusetts Institute of Technology", "name": "organizations"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "firstname": "Dan", "rank": 1, "lastname": "HURLEY"}], "original": "By DAN HURLEY"}, "document_type": "article", "pub_date": "2014-11-16T00:00:00Z", "section_name": "Magazine"}], "meta": {"hits": 8, "offset": 0, "time": 51}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}